WIN 54954
WIN 54954 is an orally active and broad-spectrum antipicornavirus agent. WIN 54954 is effectiveness against human rhinovirus, echovirus 9 and enterovirus infections[1][2].
Product Specifications
CAS Number
107355-45-3
UNSPSC
12352005
Target
Enterovirus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/win-54954.html
Purity
98.14
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=C(OCCCCCC2=CC(C)=NO2)C(Cl)=CC(C3=NCCO3)=C1
Molecular Formula
C18H20Cl2N2O3
Molecular Weight
383.27
References & Citations
[1]Woods MG, et, al. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother. 1989 Dec;33 (12) :2069-74.|[2]Fechner H, et, al. Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. Molecules. 2011 Oct 11;16 (10) :8475-503.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942858-500 1x 500 µL
CD3e (T-Cell Marker) (C3e/2858R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
